UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity

Multiple sclerosis, 2023-05, Vol.29 (6), p.763-764

2023

Link zum Volltext

Verfügbarkeit prüfen

Commentary on “Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis”

Multiple sclerosis, 2020-11, Vol.26 (13), p.1803-1804

2020

Link zum Volltext

Verfügbarkeit prüfen

Seven day pre-analytical stability of serum and plasma neurofilament light chain

Scientific reports, 2021-05, Vol.11 (1), p.11034-11034, Article 11034

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis

Current pharmaceutical design, 2022, Vol.28 (6), p.454

2022

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria

Multiple sclerosis, 2020-01, Vol.26 (1), p.69-78

2020

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?

Multiple sclerosis, 2022-01, Vol.28 (1), p.165-167

2022

Link zum Volltext

Verfügbarkeit prüfen

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis

Multiple sclerosis, 2019-02, Vol.25 (2), p.196-203

2019

Link zum Volltext

Verfügbarkeit prüfen

Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (5), p.684-694

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament light chain withstands delayed freezing and repeated thawing

Scientific reports, 2020-11, Vol.10 (1), p.19982-19982, Article 19982

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

Frontiers in neurology, 2021-08, Vol.12, p.666868-666868

2021

Link zum Volltext

Verfügbarkeit prüfen

Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years

Scientific reports, 2021-12, Vol.11 (1), p.23317-23317, Article 23317

2021

Link zum Volltext

Verfügbarkeit prüfen

Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis

PloS one, 2019-08, Vol.14 (8), p.e0220613-e0220613

2019

Link zum Volltext

Verfügbarkeit prüfen

Change of olfactory function as a marker of inflammatory activity and disability progression in MS

Multiple sclerosis, 2019-02, Vol.25 (2), p.267-274

2019

Link zum Volltext

Verfügbarkeit prüfen

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?

EBioMedicine, 2021-12, Vol.74, p.103692, Article 103692

2021

Link zum Volltext

Verfügbarkeit prüfen

Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration

Multiple sclerosis, 2020-01, Vol.26 (1), p.57-68

2020

Link zum Volltext

Verfügbarkeit prüfen

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study

PloS one, 2016-07, Vol.11 (7), p.e0158978-e0158978

2016

Link zum Volltext

Verfügbarkeit prüfen

Subarachnoid haemorrhage or traumatic lumbar puncture. Differentiation by cerebrospinal fluid parameters in a multivariable approach

Scientific reports, 2023-12, Vol.13 (1), p.22310-22310, Article 22310

2023

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Seven day pre-analytical stability of serum and plasma neurofilament light chain

Scientific reports, 2022-04, Vol.12 (1), p.6514-2, Article 6514

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

PloS one, 2021-07, Vol.16 (7), p.e0255316-e0255316

2021

Link zum Volltext

Verfügbarkeit prüfen

Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis

Multiple sclerosis, 2024-01, Vol.30 (1), p.55-62

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis

Multiple sclerosis, 2023-03, Vol.29 (3), p.374-384

2023

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis

Frontiers in immunology, 2020-04, Vol.11, p.594-594

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Multiple sclerosis, 2020-11, Vol.26 (13), p.1682-1690

2020

Link zum Volltext

Verfügbarkeit prüfen

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

Multiple sclerosis, 2021-12, Vol.27 (14), p.2209-2218

2021

Link zum Volltext

Verfügbarkeit prüfen

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis

Journal of neurology, 2021-04, Vol.268 (4), p.1247-1253

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(121)
Berichte
(1)

Sprache

Englisch
(122)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity

Commentary on “Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis”

Seven day pre-analytical stability of serum and plasma neurofilament light chain

Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria

SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis

Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis

Serum neurofilament light chain withstands delayed freezing and repeated thawing

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years

Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis

Change of olfactory function as a marker of inflammatory activity and disability progression in MS

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?

Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study

Subarachnoid haemorrhage or traumatic lumbar puncture. Differentiation by cerebrospinal fluid parameters in a multivariable approach

Author Correction: Seven day pre-analytical stability of serum and plasma neurofilament light chain

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis

Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis

Suchergebnisse filtern